MediciNova, Inc.
MNOV
$1.52
$0.000.00%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | 0.00 | 1.00M | 1.00M | 1.00M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | 0.00 | 1.00M | 1.00M | 1.00M |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | 0.00 | 1.00M | 1.00M | 1.00M |
SG&A Expenses | 5.48M | 5.04M | 4.95M | 5.11M | 5.24M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 12.68M | 11.98M | 10.82M | 11.07M | 10.90M |
Operating Income | -12.68M | -11.98M | -9.82M | -10.07M | -9.90M |
Income Before Tax | -11.04M | -10.29M | -8.16M | -8.41M | -8.57M |
Income Tax Expenses | 5.50K | 3.00K | 3.00K | 3.00K | 3.00K |
Earnings from Continuing Operations | -11.05 | -10.29 | -8.16 | -8.41 | -8.57 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -11.05M | -10.29M | -8.16M | -8.41M | -8.57M |
EBIT | -12.68M | -11.98M | -9.82M | -10.07M | -9.90M |
EBITDA | -12.65M | -11.96M | -9.80M | -10.05M | -9.88M |
EPS Basic | -0.23 | -0.21 | -0.17 | -0.17 | -0.17 |
Normalized Basic EPS | -0.14 | -0.13 | -0.10 | -0.11 | -0.11 |
EPS Diluted | -0.23 | -0.21 | -0.17 | -0.18 | -0.18 |
Normalized Diluted EPS | -0.14 | -0.13 | -0.10 | -0.11 | -0.11 |
Average Basic Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
Average Diluted Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |